Citation
Butera, Gianfranco, et al. "Migraine, Stroke and Patent Foramen Ovale: a Dangerous Trio?" Journal of Cardiovascular Medicine (Hagerstown, Md.), vol. 9, no. 3, 2008, pp. 233-8.
Butera G, Agostoni E, Biondi-Zoccai G, et al. Migraine, stroke and patent foramen ovale: a dangerous trio? J Cardiovasc Med (Hagerstown). 2008;9(3):233-8.
Butera, G., Agostoni, E., Biondi-Zoccai, G., Bresolin, N., Fumagalli, L., Chessa, M., Gallanti, A., Scacciatela, P., & Carminati, M. (2008). Migraine, stroke and patent foramen ovale: a dangerous trio? Journal of Cardiovascular Medicine (Hagerstown, Md.), 9(3), 233-8. https://doi.org/10.2459/JCM.0b013e3282058912
Butera G, et al. Migraine, Stroke and Patent Foramen Ovale: a Dangerous Trio. J Cardiovasc Med (Hagerstown). 2008;9(3):233-8. PubMed PMID: 18301138.
TY - JOUR
T1 - Migraine, stroke and patent foramen ovale: a dangerous trio?
AU - Butera,Gianfranco,
AU - Agostoni,Elio,
AU - Biondi-Zoccai,Giuseppe,
AU - Bresolin,Nereo,
AU - Fumagalli,Lorenzo,
AU - Chessa,Massimo,
AU - Gallanti,Andrea,
AU - Scacciatela,Paolo,
AU - Carminati,Mario,
PY - 2008/2/28/pubmed
PY - 2008/5/16/medline
PY - 2008/2/28/entrez
SP - 233
EP - 8
JF - Journal of cardiovascular medicine (Hagerstown, Md.)
JO - J Cardiovasc Med (Hagerstown)
VL - 9
IS - 3
N2 - The relationship between migraine, stroke and patent foramen ovale (PFO) has been the subject of considerable research efforts. Indeed, a lot of interest has focused on the potential benefits of percutaneous PFO closure. The aim of this article is to review data from the currently available literature. A total of 10 relevant studies were found in the literature, for a total of 1038 patients undergoing percutaneous PFO closure after events of cryptogenic stroke. Thirty-eight percent of these patients suffered from migraine. Combining the results of the available studies, 72% of patients were cured or improved significantly. Analysing the results according to migraine type, 81% of patients with migraine with aura had complete resolution or significantly improved as compared to 72% of patients with migraine without aura. Several limitations and drawbacks exist, however, and they are extensively discussed in this paper.
SN - 1558-2027
UR - https://www.unboundmedicine.com/medline/citation/18301138/Migraine_stroke_and_patent_foramen_ovale:_a_dangerous_trio
L2 - https://doi.org/10.2459/JCM.0b013e3282058912
DB - PRIME
DP - Unbound Medicine
ER -